Morgan Stanley, TD Cowen, BofA, Cantor Fitzgerald and Stifel acted as joint book running managers for the offering.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BCAX:
- Bicara Therapeutics announces proposed offering of $150M in common stock
- Bicara: Best-in-Class Potential for Ficerafusp Alfa in First-Line HPV-Negative Head and Neck Cancer Supports Buy Rating and $30 Target
- Bicara announces promising Phase 1b ficerafusp alfa results
- Bicara moved to Neutral from Early-Stage Biotech at Goldman Sachs
- Bicara Therapeutics announces inducement grants